Focused Technical Review Packages ↗

PACKAGE 01

GMP Gap & Inspection Readiness Review

An independent, risk-based review of GMP implementation and inspection preparedness, focused on the evidence that supports routine control and defensible quality decisions.

01 — Service objective

Identify material GMP compliance and execution gaps, assess inspection-related risks, and establish a practical, prioritized corrective-action roadmap.

02 — Recommended for

When this focused review is most useful

  1. 01

    Manufacturers preparing for regulatory inspections

  2. 02

    Sites seeking an independent GMP baseline assessment

  3. 03

    Facilities facing recurring deviations, CAPA weaknesses or execution inconsistencies

  4. 04

    New or expanding operations approaching GMP readiness

03 — Core review scope

Defined review areas

01

Pharmaceutical Quality System

  • Quality governance and accountability
  • Deviation, CAPA and change control
  • Quality risk management; document and record control
  • Self-inspection, management review and quality metrics
02

GMP Operational Controls

  • Training effectiveness and demonstrated competence
  • Production, packaging and material traceability
  • Cleaning, sanitation and contamination prevention
  • Alignment of procedures with routine execution
03

Inspection Readiness

  • Availability and traceability of critical evidence
  • Open quality risks, commitments and investigation effectiveness
  • Ability to explain and defend quality decisions
  • Consistency between documented controls and site practices

04 — Review methodology

A defined assessment. Actionable outputs.

  1. 01

    Agree facility profile, applicable GMP framework and priority risks

  2. 02

    Review selected SOPs, quality records, trends and supporting evidence

  3. 03

    Conduct interviews and process walkthroughs (remote or on-site)

  4. 04

    Classify findings by compliance significance and product/patient risk

  5. 05

    Present priorities, actions and evidence needed for closure

05 — Key deliverables

Evidence-led outputs for decisions and action

  1. 01

    GMP Gap Assessment Report

  2. 02

    Risk-Prioritized Findings Register

  3. 03

    Inspection Readiness Summary

  4. 04

    Corrective Action Roadmap

  5. 05

    Management and Technical Debrief

06 — Delivery model

Remote / On-site / Hybrid

07 — Indicative duration

2–4 weeks, depending on facility complexity, agreed sampling and evidence availability.

Subject to agreed scope and system complexity.

08 — Scope boundaries

Independent advice, with the engagement boundary stated clearly.

This is an advisory diagnostic review, not a regulatory certification or guarantee of inspection outcome. CAPA execution, SOP rewriting, validation studies and regulatory representation require separate scope.

AVISAN focused review packages are advisory, risk-based consulting assessments. They do not constitute formal GMP certification, regulatory approval, or a guarantee of inspection outcome.

09 — Request a Technical Review

Define the system, evidence and priority risks to be reviewed.